カテゴリ： MarketLine, ドイツ, 企業調査

Sandoz International GmbH：企業の戦略・SWOT・財務情報

◆英語タイトル：Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4481
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ドイツ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥23,100見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥46,200見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥69,300見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Sandoz International GmbH – Strategy, SWOT and Corporate Finance Report
Summary

Sandoz International GmbH – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sandoz International GmbH (Sandoz or ‘the company’), the generic business division of Novartis, is engaged in the development, manufacture and marketing of prescription medicines, as well as pharmaceutical active ingredients. Sandoz has its presence in the US, Europe, Asia, Africa, Australasia, Canada and Latin America. The company is headquartered in Holzkirchen, Germany.

Scope

- Detailed information on Sandoz International GmbH required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sandoz International GmbH in the form of a SWOT analysis
- An in-depth view of the business model of Sandoz International GmbH including a breakdown and examination of key business segments
- Intelligence on Sandoz International GmbH’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sandoz International GmbH, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sandoz International GmbH and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sandoz International GmbH as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sandoz International GmbH’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Sandoz International GmbH: Company Overview 8
Sandoz International GmbH: Overview and Key Facts 8
Sandoz International GmbH: Overview 8
Sandoz International GmbH: Key Facts 8
Sandoz International GmbH: Key Employees 9
Sandoz International GmbH: Key Employee Biographies 10
Sandoz International GmbH: Major Products and Services 11
Sandoz International GmbH: Company History 12
Sandoz International GmbH: Management Statement 17
Sandoz International GmbH: Locations and Subsidiaries 19
Sandoz International GmbH: Key Competitors 20
Sandoz International GmbH: Company Analysis 21
Sandoz International GmbH: Business Description 21
Sandoz International GmbH: SWOT Analysis 22
Sandoz International GmbH: SWOT Overview 22
Sandoz International GmbH: Strengths 22
Sandoz International GmbH: Weaknesses 23
Sandoz International GmbH: Opportunities 23
Sandoz International GmbH: Threats 25
Sandoz International GmbH: Corporate Financial Deals Activity 27
Sandoz International GmbH: Financial Deals Overview 27
Sandoz International GmbH: Targets and Partners 29
Sandoz International GmbH: Top Deals 2014 – 2018YTD* 30
Sandoz International GmbH: Mergers and Acquisitions 31
Sandoz International GmbH: Partnership 32
Sandoz International GmbH: Recent Developments 33
Sandoz International GmbH: News and Events Summary 33
Sandoz International GmbH: Business Expansion 36
Sandoz International GmbH: Contracts 37
Sandoz International GmbH: Financial Performance 37
Sandoz International GmbH: Regulatory and Legal Events 37
Sandoz International GmbH: Strategy and Operations 38
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42

List of Tables
Table 1: Sandoz International GmbH: Key Facts
Table 2: Sandoz International GmbH: Key Employees
Table 3: Sandoz International GmbH: Locations and Subsidiaries
Table 4: Sandoz International GmbH: Key Competitors
Table 5: Sandoz International GmbH: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sandoz International GmbH: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Sandoz International GmbH: Targets and Partners
Table 8: Sandoz International GmbH: Top Deals 2014 - 2018YTD*
Table 9: Sandoz International GmbH: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Sandoz International GmbH: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Sandoz International GmbH: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 12: Sandoz International GmbH: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 13: Sandoz International GmbH: News and Events Summary
Table 14: Sandoz International GmbH: Business Expansion
Table 15: Sandoz International GmbH: Contracts
Table 16: Sandoz International GmbH: Financial Performance
Table 17: Sandoz International GmbH: Regulatory and Legal Events
Table 18: Sandoz International GmbH: Strategy and Operations

List of Figures
Figure 1: Sandoz International GmbH: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sandoz International GmbH: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Sandoz International GmbH: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Sandoz International GmbH: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Sandoz International GmbH: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Sandoz International GmbH: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Sandoz International GmbH：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bonvests Holdings Limited：戦略・SWOT・企業財務分析
    Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Bonvests Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • PLT Health Solutions, Inc.：企業の戦略・SWOT・財務情報
    PLT Health Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary PLT Health Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tottenham Hotspur Ltd：企業の戦略的SWOT分析
    Tottenham Hotspur Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sabre Corporation (SABR)：企業の財務・戦略的SWOT分析
    Sabre Corporation (SABR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • NovoCure Ltd (NVCR)：医療機器：M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Elasmogen Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd, is a biopharmaceutical company which focuses on the development of soloMER products for the treatment of auto-inflammatory diseases, ophthalmology, oncology and intracellular delivery. soloMERs are proprietary humanized clinical can …
  • Loews Corporation：戦略・SWOT・企業財務分析
    Loews Corporation - Strategy, SWOT and Corporate Finance Report Summary Loews Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CP All Public Company Limited (CPALL)：企業の財務・戦略的SWOT分析
    CP All Public Company Limited (CPALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Sarepta Therapeutics Inc (SRPT)：製薬・医療：M&Aディール及び事業提携情報
    Summary Sarepta Therapeutics Inc (Sarepta) is discovers and develops unique RNA-targeted therapeutics, gene therapy and other genetic medicine approaches to treat rare neuromuscular diseases. The company develops drugs based on its proprietary, highly-differentiated and innovative platform technolog …
  • Bio-Modeling Systems SAS：製薬・医療：M&Aディール及び事業提携情報
    Summary Bio-Modeling Systems SAS (BM Systems) is a biotechnology company that discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as computer-assisted deductive integration (CADI), which is used in th …
  • Admedus Ltd (AHZ)：製品パイプライン分析
    Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies. Using its proprietary ADAPT engineering process, the company is developing a group of regenerative tissue bio-scaffolds for use in soft tissue r …
  • TransGlobe Energy Corp (TGL)：石油・ガス：M&Aディール及び事業提携情報
    Summary TransGlobe Energy Corp (TransGlobe Energy) is an oil and gas company that explores, develops and produces crude oil and natural gas. The company develops oil and natural gas properties in the Arab Republic of Egypt and the Republic of Yemen. It holds interests in various production sharing c …
  • BioScrip Inc (BIOS)：医療機器：M&Aディール及び事業提携情報
    Summary BioScrip Inc (BioScrip), formerly MIM Corp is a healthcare service provider that provides infusion care services. The hospital offers a range of infusion services, PBM services and respiratory services. It provides infusion therapy services such as antimicrobial drugs, factor replacement the …
  • Keio University：製薬・医療：M&Aディール及び事業提携情報
    Summary Keio University (Keio) is an educational institution that offers education and research services. The institute provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the fields of law and economics, hum …
  • Eagle Pharmaceuticals Inc (EGRX)：企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Petrosibir AB (SHEL B)：企業の財務・戦略的SWOT分析
    Summary Petrosibir AB (Petrosibir), formerly Shelton Petroleum AB is an oil and gas company. The company offers exploration and development of oil and gas assets and the resource-rich basins in Russia and Ukraine. It holds Ayazovskoye production license and Rustamovskoye exploration license that cov …
  • JACCS Co Ltd：企業の戦略・SWOT・財務分析
    JACCS Co Ltd - Strategy, SWOT and Corporate Finance Report Summary JACCS Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Repligen Corp (RGEN)：企業の財務・戦略的SWOT分析
    Summary Repligen Corp (Repligen) is a bioprocessing life science company that develops and commercializes consumable products for manufacturing biological drugs. The company's products include Protein A affinity resins, Protein A ligands, ELISA kits, alternating tangential flow system, OPUS pre pack …
  • Regenicin Inc (RGIN)：企業の財務・戦略的SWOT分析
    Summary Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patient’s own skin cells to generate living, tiss …
  • Karyopharm Therapeutics Inc (KPTI)：企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆